Description
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Valley Fever Solutions, INC, Valley Fever Center for Excellence (University of Arizona) to support the development, evaluation, and validation of diagnostic methods for coccidioidomycosis. The project will leverage the Valley Fever Center for Excellence's existing biospecimen repository and clinical infrastructure to support diagnostic assay development. The anticipated period of performance is September 30, 2026, to September 29, 2027.
Key aspects of the project include:
• Development and validation of diagnostic methods for coccidioidomycosis
• Expansion of the biospecimen repository
• Serologic assay development
• CLIA-compliant validation activities
• Collaboration with the Valley Fever Center for Excellence (VFCE)
• Access to endemic patient populations through Banner Health System clinical partnerships in Arizona